Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Four SPACs Tap Markets for $530 Million Total (Law360)

Related Content

Preparing for the EU Cyber Resilience Act: Key Reporting Obligations From 11 September 2026

Eleventh Circuit’s Zafirov Decision Leaves Key Constitutional Questions Open Regarding the FCA’s Qui Tam Provisions

DOJ’s First Healthcare Fraud Declination Under the New Corporate Enforcement Policy: Key Lessons From the Campus Eye Management Resolution and the CEO’s Continuing Exposure

DOJ Formalizes Its Global Trade Fraud Enforcement Strategy

EMTALA, Abortion Restrictions, and Potential Increased Enforcement: What Hospital Counsel Need to Know Now

$46 Million Veloxis Settlement Yields Record Sunshine Penalty and Insights Into DOJ’s Cross-Agency Data Use

Key Takeaways From the CY 2027 Medicare Physician Fee Schedule Proposed Rule

340B Drug Rebate Pilot Program Revised by HRSA

Goodwin Advises Alpha Wave on Investment in Moonwalk Biosciences’ $70M Series B Financing Round

Strategic Intent: A Legal View of Healthtech and Biopharma Trends (In Vivo)

Goodwin Advises BIOS Life on Raising $25 Million in Seed Funding

Goodwin’s Heath Ingram and Freddie Akrouche Named to Bloomberg Law’s They’ve Got Next: The 40 Under 40

Lawyers Eye CMS’ New Power To Freeze Medicaid Funds (Law360)

Goodwin Advises Paradigm Oral Health on Surgeon-Led Buyback

Goodwin Advises Small Door Veterinary on Merger With Bond Vet

Goodwin Advises Thoma Bravo on Its Strategic Growth Investment in padoa

Healthcare

Life Sciences

Private Equity

Technology

Special Purpose Acquisition Companies (SPACs)